Plasmid DNA vaccines are effective in the absence of IFNγ

被引:17
|
作者
Hassett, DE [1 ]
Zhang, J [1 ]
Whitton, JL [1 ]
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
关键词
D O I
10.1006/viro.1999.9957
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Intramuscular injection of bacterially derived plasmid DNA results in the development of both humoral and cellular immune responses against plasmid-encoded antigens. Immunostimulatory CpG sequences within bacterial DNA are thought to enhance this process by stimulating the secretion of proinflammatory cytokines such as interferon gamma (IFN gamma) by cells of the innate immune system. Although IFN gamma induction by CpG elements within plasmid DNA has been documented in vitro and more recently in vivo, and coimmunization with plasmids expressing IFN gamma has been shown to enhance DNA-immunization-induced immune responses, it is unclear if IFN gamma is necessary for successful DNA immunization. To address this issue, we compared humoral and cellular immune responses in wild-type and IFN gamma-deficient mice vaccinated with a plasmid (pCMVNP) expressing the nucleoprotein gene from the arenavirus lymphocytic choriomeningitis virus (LCMV). IFN gamma-positive (BALB/c) and IFN gamma-negative (GKO) mice responded to DNA vaccination by the development of antigen-specific CD8(+) T cells, which were detectable directly ex vivo by intracellular cytokine staining and comprised 0.7-2.5% of all CD8(+) T cells in the vaccinee. DNA vaccines also induced virus-specific cytotoxic T lymphocytes (CTL), even in the absence of IFN gamma. DNA vaccination of both mouse strains also was associated with a significant reduction in viral titers after LCMV challenge, indicating that, at least in the presence of other immune effector mechanisms, IFN gamma is not required for induction of protective anti-viral immunity by DNA immunization. No quantitative differences were observed in antiviral IgG levels among GKO and BALB/c vacciness, although GKO mice did exhibit a significant reduction of the IgG2a:IgG1 ratio, in agreement with the previously documented requirement for IFN gamma in isotype switching to IgG2a. Immunized BALB/c mice produced similar levels of both IgG1 and IgG2a, indicating a mixed Th1/Th2 response to intramuscular immunization with pCMVNP. These results show that IFN gamma induction by bacterially derived plasmid DNA does not contribute to the magnitude of the antibody response and is not required for the induction or short-term maintenance of DNA-induced CTL. However, IFN gamma is necessary for the development of IgG2a antibodies that may be crucial for protection against some pathogens. (C) 1999 Academic Press.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 50 条
  • [1] Vaccines: Developing Plasmid DNA Vaccines
    Marquet, Magda
    BIOPHARM INTERNATIONAL, 2008, : 23 - 23
  • [2] Plasmid DNA vaccines for cancer
    LoBuglio, AF
    CANCER GENE THERAPY, 2000, 7 (08) : 1203 - 1203
  • [3] Chemical adjuvants for plasmid DNA vaccines
    Greenland, John R.
    Letvin, Norman L.
    VACCINE, 2007, 25 (19) : 3731 - 3741
  • [4] CpG DNA augments the immunogenicity of plasmid DNA vaccines
    Klinman, DM
    Ishii, KJ
    Verthelyi, D
    IMMUNOBIOLOGY OF BACTERIAL CPG-DNA, 2000, 247 : 131 - 142
  • [5] Influenza Plasmid DNA Vaccines: Progress and Prospects
    Bicho, Diana
    Queiroz, Joao Antonio
    Tomaz, Candida Teixeira
    CURRENT GENE THERAPY, 2015, 15 (06) : 541 - 549
  • [6] Plasmid DNA-Based Alphavirus Vaccines
    Lundstrom, Kenneth
    VACCINES, 2019, 7 (01):
  • [7] Human clinical trials of plasmid DNA vaccines
    Liu, Margaret A.
    Ulmer, Jeffrey B.
    ADVANCES IN GENETICS, 2005, 55 : 25 - 40
  • [8] Plasmid based DNA vaccines against tuberculosis
    Shahzad, M. I.
    Khan, I.
    Khanum, A.
    Luciw, P.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : S22 - S23
  • [9] Plasmid DNA vaccines: where are we now?
    Ghaffarifar, F.
    DRUGS OF TODAY, 2018, 54 (05) : 315 - 333
  • [10] Methods to improve the immunogenicity of plasmid DNA vaccines
    Eusebio, Dalinda
    Neves, Ana R.
    Costa, Diana
    Biswas, Swati
    Alves, Gilberto
    Cui, Zhengrong
    Sousa, Angela
    DRUG DISCOVERY TODAY, 2021, 26 (11) : 2575 - 2592